From our Annual Public Meeting to topic-specific convenings, the Reagan-Udall Foundation for the FDA brings stakeholders together on matters critical to regulatory science and practice. These events, often hosted at the request of FDA leadership, provide space for expert analysis and candid discussion on FDA’s priority issues. See below for upcoming events.

Past Events

FDA to facilitate access to unapproved drugs
Biocentury coverage on the FDA’s expanded access program and collaboration with the Reagan-Udall Foundation is available here:
The FDA Sentinel Initiative: An evolving National Resource
Read The FDA Sentinel Initiative—An Evolving National Resource pubished in New Engl
Coming soon for Expanded Access Policies
Updates are coming to expanded access procedures and data use.
Expanded Access Data Can Support Approval Decisions, US FDA Says
Pink Sheet featured an article authored by Kate Rawson which highlights important takeaways from our public meeting, Leveraging Real-World Treatment Experience from Expanded Access Protocols on November 19, 2018 at the FDA
Reagan-Udall Foundation for the FDA Announces Appointment of Three New Board Members
The Reagan-Udall Foundation for the Food and Drug Administration expands its leadership with the appointment of three new Board members: Andrew C.
Winners of 2018 Innovations in Regulatory Science Awards Announced
We're excited to honor two longtime U.S.
Wasser Joins Hands On Classrooms Advisory Panel
Our Executive Director June S. Wasser has agreed to serve on the advisory panel for a new initiative of the Grocery Manufacturers Association Science and Education Foundation (GMA SEF).
Real-World Evidence to Increase Value in Health Care
Mark McClellan and his colleagues at Duke-Margolis Health Policy Center outline how real-world evidence can increase value in health care in this
Reagan-Udall Foundation at the 34th International Conference on Pharmacoepidemiology & Therapeutic Risk Management (ICPE)
During the ICPE conference, our Executive Director, June Wasser, will be discussing the importance of the Foundation’s IMEDS (Innovation in Medical Evidence Development and Surveillance) program, which provides a framework
Call for Nominations to Honor Regulatory Science Leaders
The Reagan-Udall Foundation for the Food and Drug Administration is pleased to announce the call for nominations for the 2018 Innovations in Regulatory Science Awards.